PubMed ID:
26057383
Public Release Type:
Journal
Publication Year: 2015
Affiliation: Department of Internal Medicine, Division of Nephrology, University of New Mexico, Albuqurque, New Mexico, United States of America.
DOI:
https://doi.org/10.1371/journal.pone.0129575
Authors:
Kellum JA,
Argyropoulos C,
Roumelioti ME,
Sattar A,
Unruh ML,
Weissfeld L
Request IDs:
348
Studies:
Hemodialysis Study
The bulk of randomized trial evidence for the expanding use of High Flux (HF) hemodialysis worldwide comes from two randomized controlled trials, one of which (HEMODIALYSIS, HEMO) allowed, while the other (Membrane Outcomes Permeability, MPO) excluded, the reuse of membranes. It is not known whether dialyzer reuse has a differential impact on outcomes with HF vs low flyx (LF) dialyzers.